Linear Particle Accelerators Global Market Report 2024 by The Business Research Company | Hitachi Ltd., Mitsubishi Electric Corporation, Toshiba Corporation, Siemens Healthineers, Philips, Beckman Coulter Inc., Carl Zeiss, Elekta AB, Neusoft Corporation,

The linear particle accelerators market size has grown strongly in recent years. It will grow from $2.44 billion in 2023 to $2.59 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increased demand for cancer treatment, government initiatives and funding, improved treatment outcomes, expansion of healthcare facilities, and collaboration and partnerships.

The linear particle accelerators market size is expected to see strong growth in the next few years. It will grow to $3.28 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to rising demand for precision medicine, increasing adoption of proton therapy, aging population, emerging markets, and research and development investments. Major trends in the forecast period include the integration of artificial intelligence, expansion of proton therapy, personalized medicine approaches, minimally invasive treatments, and global market expansion.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=15599&type=smp

Linear Particle Accelerators Market Major Segments
The linear particle accelerators market covered in this report is segmented -

1) By Type: Low-energy Machine, Medium-energy Machine, High-energy Machine
2) By Therapy: Radio Surgery, Radiation Therapy
3) By Applications: Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancers, Colorectal Cancers, Other Applications
4) By End User: Radiology Clinics, Hospitals, Other End Users

Key Driver - Autonomous Vehicle Adoption Driving Growth In Vehicle Radar Test System Market

The growing focus on precision medicine is expected to propel the growth of the linear particle accelerators market going forward. Precision medicine refers to an innovative approach to healthcare that tailors medical treatment and interventions to the unique characteristics of each individual patient. The growing focus on precision medicine can be attributed to advancements in genomic research and technology, recognizing the limitations of traditional healthcare approaches and the potential of tailored treatments for better outcomes. Linear particle accelerators are utilized in precision medicine to deliver targeted radiation therapy, allowing for precise tumor targeting while minimizing damage to surrounding healthy tissues. For instance, in 2022, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the growing focus on precision medicine is driving the growth of the linear particle accelerators market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=15599&type=smp

Prominent Trend - Advancements In AI-Powered CT-Linac Technology To Transform Cancer Care

Major companies operating in the linear particle accelerators market are developing innovative solutions, such as AI-powered adaptive computed tomography linear particle accelerators (CT-Linac), to revolutionize cancer treatment by offering enhanced precision, personalized therapy, and real-time imaging capabilities for improved patient outcomes. AI-powered adaptive computed tomography linear particle accelerators are advanced medical devices that integrate artificial intelligence algorithms with computed tomography technology and particle acceleration capabilities to provide precise, personalized radiation therapy treatments with real-time imaging and adaptive treatment planning. For instance, in May 2024, Elekta, a Sweden-based human care company, launched Elekta Evo, an AI-powered, adaptive CT-Linac. This linear particle accelerator, specifically designed for use in radiation therapy, offers clinicians unprecedented precision and versatility in cancer treatments. Evo gives physicians unprecedented levels of accuracy and adaptability in cancer therapies because of its next-generation image quality and online adaptability capabilities. Elekta Evo uses cutting-edge imaging technologies, anatomy-specific algorithms, and potent AI to optimize treatment planning, minimize injury to organs at risk, and reduce uncertainty.

Linear Particle Accelerators Market Players
Major companies operating in the linear particle accelerators market are Hitachi Ltd., Mitsubishi Electric Corporation, Toshiba Corporation, Siemens Healthineers, Philips, Beckman Coulter Inc., Carl Zeiss, Elekta AB, Neusoft Corporation, Shinva Medical Instrument Co. Ltd., ALCEN, Laird Technologies, Accuray Incorporated, Brainlab AG, AccSys Technology, Mevion Medical Systems, Viewray Medical Technologies Inc., RefleXion Medical, Panacea Medical Technologies Pvt. Ltd., Altair Technologies, Sordina lort Technologies, MedAustron, LUM GmbH, IBA Group, P-Cure Ltd.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/linear-particle-accelerators-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the linear particle accelerators market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the linear particle accelerators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Linear Particle Accelerators Market Report Structure
3. Linear Particle Accelerators Market Trends And Strategies
4. Linear Particle Accelerators Market - Macro Economic Scenario
5. Linear Particle Accelerators Market Size And Growth
…..
27. Linear Particle Accelerators Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.